Electronic Medical Records and Genomics (eMERGE) Phase III

Summary

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clinically relevant, actionable genes. The genetic results will be returned to participants and outcomes tracked through the electronic health records.

Conditions

• Cardiac Disease
• Cancer
• Hypercholesterolemia
• Diabetes
• Kidney Diseases
• Neuromuscular Diseases

Sponsors & Collaborators

• Vanderbilt University Medical Center

  lead OTHER

Principal Investigators

• Teri Manolio, MD, PhD · National Human Genome Research Institute (NHGRI)

• John Harley, MD, PhD · Children's Hospital Medical Center, Cincinnati

• Hakon Hakonarson, MD, PhD · Children's Hospital of Philadelphia

• Chunhua Weng, PhD · Columbia University

• Marc Williams, MD · Geisinger Clinic

• Elizabeth Karlson, MD · Harvard University

• Scott Hebbring, PhD · Marshfield Clinic

• Iftikhar Kullo, MD · Mayo Clinic

• Samuel Adunyah, PhD · Meharry Medical College

• Rex Chisholm, PhD · Northwestern University

• Gail Jarvik, MD, PhD · Kaiser Permanente Washington with the University of Washington and the Fred Hutchinson Cancer Research Center

• Dan Roden, MD · Vanderbilt University Medical Center

• Heidi Rehm, PhD · Partners Healthcare with Broad Institute

• Richard Gibbs, PhD · Baylor College Medicine

Eligibility

Min Age

1 Day

Max Age

120 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2015-09-01

Primary Completion

2020-04-01

Completion

2020-04-01